$21.06
Price
$3.4B
Market Cap
—
P/E Ratio
-83.3
Forward P/E
$-0.32
EPS (TTM)
—
Dividend Yield
$218M
Cash
$79M
Total Debt
160M
Shares Out
$9.96
$22.80
52-Week Range
Institutional Ownership of ADAPTIVE BIOTECHNOLOGIES
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for ADAPTIVE BIOTECHNOLOGIES
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | +104.7% | 291.2K | $4M | $12.54 | |
| 2025-Q2 | |||||
| BUY | NEW | 142.3K | $2M | $9.09 | |
| 2020-Q4 | |||||
| SELL | -10.4% | 30.0M | $1.8B | $49.99 | |
| 2020-Q1 | |||||
| SELL | -12.8% | 33.5M | $930M | $29.39 | |
| 2019-Q2 | |||||
| BUY | NEW | 38.4M | $1.9B | $44.30 | |
Insider Trading for ADAPTIVE BIOTECHNOLOGIES
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.